Literature DB >> 19802516

The intertwisted correlations among non-alcoholic fatty liver disease, atherosclerosis, and metabolic syndrome.

Haruhisa Nakao, Masashi Yoneda.   

Abstract

Entities:  

Mesh：

Year:  2009        PMID： 19802516     DOI： 10.1007/s00535-009-0140-9

Source DB:  PubMed          Journal:  J Gastroenterol        ISSN： 0944-1174            Impact factor:   7.527


× No keyword cloud information.
  27 in total

Review 1.  Nonalcoholic fatty liver disease.

Authors:  Paul Angulo
Journal:  N Engl J Med       Date:  2002-04-18       Impact factor: 91.245

2.  Nonalcoholic fatty liver disease and risk of future cardiovascular events among type 2 diabetic patients.

Authors:  Giovanni Targher; Lorenzo Bertolini; Felice Poli; Stefano Rodella; Luca Scala; Roberto Tessari; Luciano Zenari; Giancarlo Falezza
Journal:  Diabetes       Date:  2005-12       Impact factor: 9.461

Review 3.  gamma-Glutamyltransferase is a promising biomarker for cardiovascular risk.

Authors:  Okan Turgut; Ahmet Yilmaz; Kenan Yalta; Filiz Karadas; M Birhan Yilmaz
Journal:  Med Hypotheses       Date:  2006-08-07       Impact factor: 1.538

4.  Non-alcoholic hepatic steatosis and its relation to increased plasma biomarkers of inflammation and endothelial dysfunction in non-diabetic men. Role of visceral adipose tissue.

Authors:  G Targher; L Bertolini; L Scala; G Zoppini; L Zenari; G Falezza
Journal:  Diabet Med       Date:  2005-10       Impact factor: 4.359

5.  Nonalcoholic fatty liver, steatohepatitis, and the metabolic syndrome.

Authors:  Giulio Marchesini; Elisabetta Bugianesi; Gabriele Forlani; Fernanda Cerrelli; Marco Lenzi; Rita Manini; Stefania Natale; Ester Vanni; Nicola Villanova; Nazario Melchionda; Mario Rizzetto
Journal:  Hepatology       Date:  2003-04       Impact factor: 17.425

6.  Serum gamma-glutamyltransferase within its normal concentration range is related to the presence of diabetes and cardiovascular risk factors.

Authors:  D-J Kim; J-H Noh; N-H Cho; B-W Lee; Y-H Choi; J-H Jung; Y-K Min; M-S Lee; M-K Lee; K-W Kim
Journal:  Diabet Med       Date:  2005-09       Impact factor: 4.359

7.  Nonalcoholic fatty liver disease and carotid atherosclerosis in children.

Authors:  Lucia Pacifico; Vito Cantisani; Paolo Ricci; John F Osborn; Elisa Schiavo; Caterina Anania; Eva Ferrara; Giuliano Dvisic; Claudio Chiesa
Journal:  Pediatr Res       Date:  2008-04       Impact factor: 3.756

8.  The Metabolic Syndrome is an independent predictor of cardiovascular disease in Type 2 diabetic subjects. Prospective data from the Verona Diabetes Complications Study.

Authors:  E Bonora; G Targher; G Formentini; F Calcaterra; S Lombardi; F Marini; L Zenari; F Saggiani; M Poli; S Perbellini; A Raffaelli; L Gemma; L Santi; R C Bonadonna; M Muggeo
Journal:  Diabet Med       Date:  2004-01       Impact factor: 4.359

9.  Hepatic steatosis, carotid atherosclerosis and metabolic syndrome: the STEATO Study.

Authors:  Claudio Carallo; Gerardo Mancuso; Gaetano Mauro; Ferdinando Laghi; Bruno Madafferi; Concetta Irace; Agostino Gnasso; Faustina Scavelli; Ferruccio Dell'Aquila; Mosè Bartone; Francesco Gullo; Maria Ferraro; Vitaliano Spagnuolo; Maria Belmonte; Antonio Ferrara; Antonio Silvano Rotondaro; Nicola Brandolino; Francesca Parasporo; Francesco Scopelliti
Journal:  J Gastroenterol       Date:  2009       Impact factor: 7.527

Review 10.  Metabolic syndrome and NASH.

Authors:  Giulio Marchesini; Rebecca Marzocchi
Journal:  Clin Liver Dis       Date:  2007-02       Impact factor: 6.126
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.